Sato Kazuki, Miyashita Mitsunori, Morita Tatsuya, Sanjo Makiko, Shima Yasuo, Uchitomi Yosuke
Department of Adult Nursing/Palliative Care Nursing, School of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Bunkyo, Tokyo, Japan.
Support Care Cancer. 2008 Feb;16(2):113-22. doi: 10.1007/s00520-007-0332-x. Epub 2007 Oct 5.
In Japan, most cancer patients die in the hospital. The aim of this study was to assess the quality of end-of-life treatment for dying cancer patients in general wards and palliative care unit (PCU).
A retrospective chart review study was conducted. The following data on cancer patients who died in general wards (N = 104) and PCU (N = 201) at a regional cancer center were collected: do-not-resuscitate (DNR) decisions, treatments in the last 48 h of life, and aggressiveness of cancer care for dying patients.
DNR orders were documented for most patients (94% in general wards, 98% in PCU, p = 0.067) and families usually consented (97%, 97%, p = 0.307). Comparison of general wards with PCU showed that, in the last 48 h of life, significantly more patients in general wards received life-sustaining treatment (resuscitation, 3.8%, 0%, p = 0.001; mechanical ventilation, 4.8%, 0%, p = 0.004), large volume hydration (>1,000 ml/day, 67%, 10%, p < 0.001) with continuous administration (83%, 5%, p = 0.002) and fewer palliative care drugs (strong opioids, 68%, 92%, p < 0.001; corticosteroids, 49%, 70%, p < 0.001; nonsteroidal anti-inflammatory drugs, 34%, 85%, p < 0.001). Regarding aggressiveness of cancer care, patients received a new chemotherapy regimen within 30 days of death (3.0%), chemotherapy within 14 days of death (4.3%), and intensive care unit admission in the last month of life (3.3%).
We found that families, not patients, consented to DNR, and life-sustaining treatments were appropriately withheld; however, patients on general wards received excessive hydration, and the use of palliative care drugs could be improved. Application of our findings can be used to improve clinical care in general wards.
在日本,大多数癌症患者在医院死亡。本研究的目的是评估综合病房和姑息治疗病房(PCU)中临终癌症患者的临终治疗质量。
进行了一项回顾性病历审查研究。收集了某地区癌症中心在综合病房死亡的癌症患者(N = 104)和在PCU死亡的癌症患者(N = 201)的以下数据:不进行心肺复苏(DNR)决策、生命最后48小时的治疗以及对临终患者的癌症治疗积极程度。
大多数患者有DNR医嘱记录(综合病房为94%,PCU为98%,p = 0.067),且家属通常表示同意(分别为97%、97%,p = 0.307)。综合病房与PCU的比较显示,在生命的最后48小时,综合病房中接受维持生命治疗的患者明显更多(心肺复苏,3.8%,0%,p = 0.001;机械通气,4.8%,0%,p = 0.004),大量补液(>1000毫升/天,67%,10%,p < 0.001)且持续给药(83%,5%,p = 0.002),而姑息治疗药物使用较少(强效阿片类药物,68%,92%,p < 0.001;皮质类固醇,49%,70%,p < 0.001;非甾体抗炎药,34%,85%,p < 0.001)。关于癌症治疗的积极程度,患者在死亡前30天内接受新的化疗方案(3.0%),在死亡前14天内接受化疗(4.3%),以及在生命的最后一个月入住重症监护病房(3.3%)。
我们发现是家属而非患者同意DNR,且维持生命的治疗被适当放弃;然而,综合病房的患者接受了过度补液,姑息治疗药物的使用可以改进。应用我们的研究结果可用于改善综合病房的临床护理。